Atai Life Sciences N.V. (FRA:9VC)
Germany · Delayed Price · Currency is EUR 4.407
-0.337 (-7.10%)
Last updated: Sep 30, 2025, 8:01 AM CET
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of €995.73 million as of September 30, 2025. Its market cap has increased by 432.38% in one year.
Market Cap
995.73M
Enterprise Value
924.09M
Revenue
1.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.41
Market Cap Chart
Since June 18, 2021, Atai Life Sciences's market cap has decreased from 2.50B to 995.73M, a decrease of -60.22%. That is a compound annual growth rate of -19.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 995.73M | 361.91% |
| Dec 31, 2024 | 215.57M | 1.79% |
| Dec 29, 2023 | 211.77M | -48.71% |
| Dec 30, 2022 | 412.86M | -61.61% |
| Dec 31, 2021 | 1.08B | -57.03% |
| Jun 18, 2021 | 2.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 262.21B |
| Siemens Aktiengesellschaft | 177.42B |
| Deutsche Telekom AG | 136.77B |
| Allianz SE | 136.28B |
| Rheinmetall AG | 89.95B |
| Siemens Energy AG | 84.11B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.76B |
| Deutsche Bank Aktiengesellschaft | 58.48B |